Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer

被引:3
|
作者
Pantelis, Dimitrios [1 ]
Lingohr, Philipp [1 ]
Hueneburg, Robert [2 ]
Spier, Isabel [3 ]
Vilz, Tim [1 ]
Lau, Jan F. [4 ]
Nattermann, Jacob [2 ]
Aretz, Stefan [2 ]
Strassburg, Christian P. [2 ]
Kalff, Joerg C. [1 ]
机构
[1] Univ Klinikum Bonn, Klin & Poliklin Allgemein Viszeral Thorax & Gefas, Bonn, Germany
[2] Univ Klinikum Bonn, Medizin Klin & Poliklin 1, Allgemeine Innere Med, Bonn, Germany
[3] Univ Klinikum Bonn, Inst Humangenet, Bonn, Germany
[4] Univ Klinikum Bonn, Inst Pathol, Bonn, Germany
来源
ZENTRALBLATT FUR CHIRURGIE | 2020年 / 145卷 / 01期
关键词
hereditary diffuse gastric cancer; CDH1 germline mutation; prophylactic total gastrectomy; laparoscopic surgery; E-CADHERIN GENE; CLASSIFICATION; COMPLICATIONS; GUIDELINES; MANAGEMENT; MUTATIONS; COHORT; FOCI;
D O I
10.1055/a-0646-4382
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction Prophylactic total gastrectomy is the treatment of choice in patients with germline mutation in the CDH1 gene and therefore high risk for hereditary diffuse gastric cancer (HDGC). Minimally invasive techniques have been established in recent years for treatment of gastric cancer. Methods We report findings with 12 patients with proven CDH1 mutation who underwent multidisciplinary treatment between 2013 and 3/2018 in our centre for hereditary tu-mour diseases, followed by prophylactic total gastrectomy in our department. Data were collected in a prospective hereditary tumour database. Results Open prophylactic total gastrectomy was performed in 5 patients (between 2013 and 2015) andminimally invasive prospective gastrectomy in 7 patients (between 2015 and 2018). The median age of all patients (7 women and 5 men) was 42 (range: 19-60) years. The mean operation time was 291 +/- 72 minutes (open: 269 +/- 70; minimally invasive: 307 +/- 75). Perioperative 60-day mortality and anastomotic leakage rate were 0%. In 3 patients, postoperative complications occurred (according to the Clavien-Dindo classification: one each of grades II, IIIa and IVb, respectively), and therefore 25% morbidity. The average postoperative hospital stay was 14.5 +/- 6.2 days (open: 16.2 +/- 7.9; minimally invasive: 13.3 +/- 5.0). In 10 of 12 patients (83%), foci of intramucosal signet ring cell carcinomas were found in the gastric specimen, in 9 patients with multifocal dissemination. There were no cases with advanced carcinomas (>= pT1b) or lymph node metastases. Conclusion Patients with suspected high risk for hereditary diffuse gastric cancer should be cared for in a multidisciplinary centre for hereditary tumour diseases. Laparoscopic total gastrectomy is a safe and feasible risk-reducing procedure for patients with CDH1 germline mutation. Therefore, in the absence of contraindications and with available surgical expertise, the minimally invasive operation should be the standard procedure for these patients.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [21] Usefulness of prophylactic gastrectomy in a novel large hereditary diffuse gastric cancer (HDGC) family
    Caron, Olivier
    Schielke, Astrid
    Svrcek, Magali
    Flejou, Jean-Francois
    Garzon, Jacob
    Olschwang, Sylviane
    Sezeur, Alain
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (08): : 2160 - 2161
  • [22] Shifting perceptions on endoscopic surveillance and timing of prophylactic gastrectomy for hereditary diffuse gastric cancer
    van Dieren, Jolanda M.
    van der Post, Rachel S.
    Bisseling, Tanya M.
    BRITISH JOURNAL OF SURGERY, 2023, 110 (09) : 1028 - 1029
  • [23] Prophylactic minimally invasive gastrectomy in hereditary diffuse gastric cancer: a case series report
    Murphy, B. C.
    Murphy, T. J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S161 - S161
  • [24] Prophylactic Laparoscopic Gastrectomy for Hereditary Diffuse Gastric Cancer: A Case Series in a Single Family
    Hackenson, David
    Edelman, David A.
    McGuire, Tim
    Weaver, Donald W.
    Webber, John D.
    JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS, 2010, 14 (03) : 348 - 352
  • [25] CDH1 Testing: Can it Predict the Prophylactic or Therapeutic Nature of Total Gastrectomy in Hereditary Diffuse Gastric Cancer?
    Ziogas, Dimosthenis
    Roukos, Dimitrios H.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (10) : 2678 - 2681
  • [26] CDH1 Testing: Can it Predict the Prophylactic or Therapeutic Nature of Total Gastrectomy in Hereditary Diffuse Gastric Cancer?
    Dimosthenis Ziogas
    Dimitrios H. Roukos
    Annals of Surgical Oncology, 2009, 16 : 2678 - 2681
  • [27] Prophylactic total gastrectomy for familial gastric cancer
    Lewis, FR
    Mellinger, JD
    Hayashi, A
    Lorelli, D
    Monaghan, KG
    Carneiro, F
    Huntsman, DG
    Jackson, CE
    Caldas, C
    SURGERY, 2001, 130 (04) : 612 - 617
  • [28] Indication for the prophylactic total gastrectomy in the hereditary diffuse gastric cancer in carriers of E-Cadherin mutation. Two observations
    Godlewski, G.
    Chiesa, J.
    Pujol, P.
    Bourgaud, J. F.
    Pignodel, C.
    Prudhomme, M.
    E-MEMOIRES DE L ACADEMIE NATIONALE DE CHIRURGIE, 2007, 6 (01): : 7 - 12
  • [29] Preemptive Total Gastrectomy for Hereditary Gastric Cancer
    Heriberto Medina-Franco
    Rafael Barreto-Zuñiga
    Miriam N. García-Alvarez
    Journal of Gastrointestinal Surgery, 2007, 11 : 314 - 317
  • [30] Preemptive total gastrectomy for hereditary gastric cancer
    Medina-Franco, Heriberto
    Barreto-Zuniga, Rafael
    García-Alvarez, Miriam N.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (03) : 314 - 317